Financial Gravity Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-29
Closed -$14.2K 926
2025
Q3
$14.2K Buy
+29
New +$13.5K ﹤0.01% 504
2024
Q2
Sell
-2
Closed -$1.29K 1758
2024
Q1
$1.29K Hold
2
﹤0.01% 720
2023
Q4
$1.5K Buy
+2
New +$968 ﹤0.01% 751
2021
Q3
$571K Sell
1
-19
-95% -$10.4K 0.27% 70
2021
Q2
$514K Buy
+20
New +$9.44K 0.18% 81
2020
Q4
$3K Buy
+7
New +$3.28K ﹤0.01% 289
2019
Q4
$325K Sell
135
-45
-25% -$13.6K 0.22% 47
2019
Q3
$52K Buy
180
+10
+6% +$2.86K 0.04% 285
2019
Q2
$50K Sell
170
-84
-33% -$23.1K 0.04% 321
2019
Q1
$70K Buy
+254
New +$63.2K 0.06% 251
2018
Q3
$13K Sell
57
-473
-89% -$109K 0.01% 533
2018
Q2
$123K Buy
530
+485
+1,078% +$103K 0.12% 181
2018
Q1
$9K Buy
+45
New +$9.45K 0.01% 609

Other funds holding TMO

Financial Gravity Asset Management's TMO Position: Q4 2025 in Review

Financial Gravity Asset Management sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 29 shares — an estimated $14.2K sold.

Financial Gravity Asset Management first reported a position in TMO in Q1 2018 and held it in 13 quarters. The position peaked at $571K in Q3 2021. 2,705 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Financial Gravity Asset Management reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Financial Gravity Asset Management sold 29 Thermo Fisher Scientific shares in Q4 2025, an estimated $14.2K.
  • Financial Gravity Asset Management first reported a position in Thermo Fisher Scientific in Q1 2018 and held it in 13 quarters.
  • Financial Gravity Asset Management's Thermo Fisher Scientific position peaked at $571K in Q3 2021.
  • 2,705 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Financial Gravity Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.